Medicare patients with highest COVID risks were less likely to get treatment, study finds. marketwatch.com/story/medicare… Michael L. Barnett HMS HCP

Our WSJ D.C. bureau lost some of its best editors and reporters today. It's been absolutely gutting, and they all have families and lives to think about. Please remember there are human beings sacrificing a whole lot to bring you the news and hold people in power to account.

So many talented and hardworking WSJ editors and reporters were laid off today in Washington. Our bureau will never be the same. Please hire them! Our tremendous loss can be your gain.

As pharma execs face drug-price grilling on Capitol Hill, experts cite deeper problems under the radar marketwatch.com/story/merck-j-… Antonio Ciaccia 46brooklyn Research

“With government programs getting an 80% discount on Eliquis, lawmakers asking why the price of the drug is so high might get better answers from a mirror than from the pharmaceutical executives themselves.” Antonio Ciaccia marketwatch.com/story/merck-j-… Eleanor Laise MarketWatch

Do we simply not care about older adults? So many reasons to wonder why -- society's response to ongoing covid deaths, pervasive ageism, and more. So, I took this on in a new column. cnn.com/2024/02/08/hea…

"We may not have the right bad guys here," Sen. Romney said at today's drug-pricing hearing with CEOs of Merck, J&J, and Bristol Myers Squibb. marketwatch.com/story/j-j-merc…

While weight loss may be an important factor behind Wegovy's benefits for heart-failure patients, it's not the whole story, new research shows. Mikhail Kosiborod @midamericaheart Saint Luke's marketwatch.com/story/wegovys-…

1 in 3 women skip mammograms when faced with job loss and other hurdles, CDC says marketwatch.com/story/one-in-t…

More young adults are turning to sterilization in the wake of the Supreme Court's Dobbs decision, new research finds. Jackie Ellison, PhD Pitt Health Policy and Management marketwatch.com/story/more-you…

The ketamine therapy business is booming--but some industry insiders fear patients are being put at risk. marketwatch.com/story/as-ketam…

Had a great talk with Jeremy C. Owens about the ups and downs of ketamine therapy. marketwatch.com/podcasts/on-wa…

It's World Press Freedom Day. Evan Gershkovich, has had his freedom deprived for more than 400 days, simply for doing his job as a reporter. He is sitting in a Russian prison instead of chronicling events outside of it. We cannot say it loud enough: Free Evan. #IStandWithEvan

New blood test for strokes could help tackle a $2 trillion problem, researchers say. marketwatch.com/story/new-bloo… Joshua Bernstock Brigham and Women's Neurosurgery

Pandemic-related stress affected babies' brain development, researchers find marketwatch.com/story/pandemic… Developing Brain Institute at Children's National Children's National Hospital 🏥

Tampon toxic-metals scare follows years of warnings about oversight gaps marketwatch.com/story/tampon-t… Jenni Shearston @UCBerkeleySPH Alexandra Scranton Women's Voices for the Earth (WVE) @DeviceEvents

Alzheimer's risk may be sharply reduced with these cheap drugs, research shows. marketwatch.com/story/alzheime… #Neurology #AANscience

Those 65 or older or immunocompromised have greater risk of more severe infections and should talk to their doctors about the best timing for fall COVID vaccinations, notes Sameer Vohra, director of IDPH | Illinois Department of Public Health. More from Eleanor Laise of MarketWatch: marketwatch.com/story/5-things…. #NIAM24

The Zepbound changes that $LLY announced yesterday were widely hailed as a "price cut." But there's more to the story. marketwatch.com/story/eli-lill… MarketWatch

Are medical bills making you sick? Here’s why it’s worth challenging them. trib.al/wPSUXjr